Citi Investment Research has a Buy rating and is raising its price target on Universal American UAM to $22 from $19.
In the research report, Citi writes, "After CVS pays $13 / share for the PDP segment, the market is valuing the remaining Universal business at around $7.45 per share. As Universal noted in its press release, the remaining business will have cash and statutory capital of $640 million at the end of 2010, or $8 per share. Universal will need less than $400 million of statutory capital to support its remaining revenue, by our calculation, suggesting there's more than $200 million ($2.50 per share) in capital that can be deployed to shareholders, on top of the ongoing earnings stream of the business, which we estimate at around $0.75 per share. Our price target rises from $19 to $22."
Shares of UAM gained $5.84 on Friday to close at $20.45, a gain of nearly 40%.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in